Synapse - Steven Horwitz

Results (664)

Safety of mogamulizumab in mycosis fungoides and Sézary syndrome: Final results from the phase 3 MAVORIC study

Meeting Abstract

Kim, Y. H.; Bagot, M.; Zinzani, P. L.; Duvic, M.; Morris, S.; Kim, E.; Musiek, A.; Ortiz-Romero, P. L.; Elmets, C.; Eradat, H. A.; more...
Blood (2019)

Fulltext@MSK | Save

A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; more...
Blood (2019)

Fulltext@MSK | Save

Dose optimization of duvelisib in patients with relapsed or refractory peripheral T-cell lymphoma from the phase 2 PRIMO trial: Selection of regimen for the dose-expansion phase

Meeting Abstract

Horwitz, S. M.; Mehta-Shah, N.; Pro, B.; Jacobsen, E. D.; Casulo, C.; Brammer, J. E.; Haney, J.; Youssoufian, H.; Weaver, D. T.; Baglio, M.; more...
Blood (2019)

Fulltext@MSK | Save

Incidence of delayed seromas and related risk of BIA-ALCL in a cohort of 3521 breast cancer women with textured implants prospectively followed long term

Meeting Abstract

Ghione, P.; Cordeiro, P.; Seshan, V.; Galasso, N.; Ganesan, N.; Hu, Q.; Dogan, A.; Horwitz, S. M.
Blood (2019)

Fulltext@MSK | Save

Contemporary outcomes in HTLV-1-associated adult T-cell leukemia/lymphoma: Single-institution experience

Meeting Abstract

Epstein-Peterson, Z. D.; Ghione, P.; Moskowitz, A. J.; Dahi, P. B.; Dogan, A.; Kumar, A.; Matasar, M. J.; Noy, A.; Perales, M. A.; Ponce, D. M.; more...
Blood (2019)

Fulltext@MSK | Save

Characteristics, treatment patterns, and outcomes in primary cutaneous gamma delta T cell lymphoma (PCGDTCL): A real world multi-institutional analysis of a rare malignancy

Meeting Abstract

David, K. A.; Pulitzer, M.; Guitart, J.; Martinez-Escala, M. E.; Geller, S.; Wang, Y.; Bennani, N. N.; Ristow, K. M.; Landsburg, D. J.; Winchell, N.; more...
Blood (2019)

Fulltext@MSK | Save

Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era

Meeting Abstract

Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; more...
Blood (2019)

Fulltext@MSK | Save

The ECHELON-2 trial: Results of a randomised, double-blind, active-controlled phase 3 study of brentuximab vedotin and CHP (A plus CHP) vs CHOP in the frontline treatment of patients (pts) with CD30(+) peripheral T-cell lymphomas (PTCLs)

Meeting Abstract

Trümper, L.; O'Connor, O. A.; Pro, B.; Illidge, T. M.; Advani, R. H.; Bartlett, N. L.; Christensen, J. H.; Morschhauser, F.; Domingo-Domenech, E.; Rossi, G.; more...
Oncology Research and Treatment (2019)

Fulltext@MSK | Save

An exploratory analysis of brentuximab vedotin plus CHP (A plus CHP) in the frontline treatment of patients with CD30+ peripheral T-cell lymphomas (ECHELON-2): Impact of consolidative stem cell transplant

Meeting Abstract

Savage, K. J.; Horwitz, S. M.; Advani, R. H.; Christensen, J. H.; Domingo-Domenech, E.; Rossi, G.; Morschhauser, F.; Alpdogan, O.; Suh, C.; Tobinai, K.; more...
Blood (2019)

Fulltext@MSK | Save

A phase 2 study of the dual SYK/JAK inhibitor cerdulatinib demonstrates good tolerability and clinical response in relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma

Meeting Abstract

Horwitz, S. M.; Feldman, T. A.; Hess, B. T.; Khodadoust, M. S.; Kim, Y. H.; Munoz, J.; Patel, M. R.; Phillips, T. J.; Smith, S. D.; Smith, S. M.; more...
Blood (2019)

Fulltext@MSK | Save

Steven M Horwitz

Results (664)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract